Sign In

Naomi Fried

CEO & Founder PharmStars; Managing Partner & Co-founder, Ambit Health Ventures

Naomi Fried is a distinguished leader in innovation strategy, management, and healthcare infrastructure, renowned for creating the innovative 'Innovation Life Cycle' paradigm. With over 20 years of experience, she specializes in digital health, including telehealth, and is deeply passionate about its potential to revolutionize healthcare.

As the CEO of Health Innovation Strategies (HealthIS), a prominent boutique consulting firm, Naomi leverages her extensive background as an innovation leader to assist major healthcare organizations in developing, designing, and optimizing their innovation programs and digital health strategies.

Notably, as the former Chief Innovation Officer at Boston Children's Hospital and the first Vice President of Innovation and Advanced Technology at Kaiser Permanente, Naomi has spearheaded groundbreaking initiatives such as the Innovation Acceleration Program. Further, at Biogen, she formulated the visionary 'Innovation Beyond the Molecule' program, showcasing her adeptness in conceptualizing and managing innovative ventures.

Naomi Fried possesses a wealth of experience in both corporate and startup environments, with profound expertise spanning the provider, payer, and pharmaceutical sectors. Her academic background as a research scientist underpins her strategic approach to healthcare innovation. She excels in fostering innovation and has a remarkable record of assembling and leading highly skilled teams.

Her specialties encompass a broad spectrum of healthcare domains, including innovation management, digital transformation, telemedicine, and healthcare IT. Naomi's commitment to advancing healthcare is further evidenced by her board memberships with the American Telemedicine Association and the Massachusetts' Innovation Council.

Naomi Fried's educational journey includes a Bachelor of Science in Chemistry from the University of California, Berkeley, and a Ph.D. in Materials Science Engineering from the Massachusetts Institute of Technology.

In addition to her leadership at Health Innovation Strategies, Naomi has held several influential roles in noteworthy organizations, such as Founder and CEO at PharmStars and Managing Partner at Ambit Health Ventures. She has also made significant contributions as a Board Member at various healthcare-focused companies.

Highlights

Jun 28 · linkedin

📣 Attention #VCs: Do you have a #digitalhealth #startup 🚀 with an #innovation related to “Therapeutic Delivery” in your portfolio that wants to do business with #pharma? If they have only a few (or no) pharma clients, 💥PharmStars can provide them with access to many more potential pharma clients.   Startups in our #acceleratorprogram have the unique opportunity to pitch to and meet one-on-one with our pharma members at our private Showcase Event. It's an amazing way to accelerate a startup's pharma #businessdevelopment pipeline! There were 60+ one-on-one, private pharma-startup meetings 🤝 at our Showcase Event in May.   Our virtual, #pharmastartupgap-focused #accelerator coaches and educates startups on how to optimize their pharma value proposition-- which leads to successful business engagements with pharma. Even participants with 15+ years of pharma experience gain valuable insights from our educational #PharmaU program. PharmaU also includes personalized coaching by seasoned former pharma executives.   No #equity required to participate in our #acceleratorprogram- just tuition and a success payment when deals are closed.   Startups can be of any age/stage welcome, but must have a product or prototype to offer pharma now.  We have had pre-seed through Series B startups thrive in our program.   Areas of interest include, but are not limited to:   🌟Novel drug delivery/ administration platforms 💡 Companion devices 💡 Dynamic dosing   🌟Supply chain management or efficiency 💡 Sourcing, logistics, distribution, inventory, compliance 💡 Product integrity, tracking anti-counterfeiting 💡 Supply and delivery for advanced therapies (cell, gene, etc.) 💡 Sustainability and recycling   🌟 Treatment management 💡 Patient education, health literacy 💡 Medication adherence and persistence 💡 Remote patient monitoring 💡 Avoiding and/or detecting drug-drug interactions 💡 Detection, monitoring, measuring, managing or reporting side effects   ⏰ Hurry! Time is running out! The application deadline is July 10.   Info and applications 👉 https://lnkd.in/d-Qe7R4y   #venturecapital #Investment #entrepreneur #Investors #transformation #partnerships #biotech #bizdev #engagement #financing #funding #biopharma

Mar 14 · linkedin

Today we continue PharmStars' tribute🎉 to the fabulous #femalefounders who have graduated from our #accelerator during Women’s (Making!) History Month. I am delighted to feature 4 founders and CEOs from our Spring 2022 cohort focused on #digitalhealth #innovations in #NeurologicalDisease:

Teri Chou is CEO of Modus Health (Edmonds, WA), a validated, real world #mobility assessment tool. Modus’ #wearable and #digitalendpoints are used worldwide for a more reliable measure of walking quantity, intensity, and duration.  In a comparison study, Modus demonstrated superior accuracy of 98%. We congratulate Modus on actively supporting a Phase 3 trial in 55 sites worldwide!

Patty Lee is CEO of Orbit Health (Munich, Germany), an #AI-enabled, wearable-agnostic platform to track and evaluate #ParkinsonsDisease. Their platform, which uses commercially available smart watches, offers objective, convenient, minute-by-minute information on #motorsymptoms and treatment responses in real world settings. Orbit Health’s system has been validated and tracks disease progression and supports treatment #personalization, enhancing patient engagement, and care optimization.

Charisse Litchman is co-founder and Chief Medical Officer at BeCare Link (Rumson, NJ), a gamified, #mobileapp for #AI-enabled #neurologicalassessment. BeCare Link delivers a remote, #quantitative assessment of neurological function with AI analysis, from data it collects along with other digital biomarkers. BeCare Link provides clinicians and investigators a more sensitive, reliable, faster, and more #comprehensive neurological evaluation than standard clinical assessments.

Carla Zaldua Aguirre is CEO of acceXible (Barcelona, Spain), a device-agnostic #speechbiomarker platform for #screening and monitoring #mildcognitiveimpairment and early #dementia with a sensitivity of 91% and a specificity of 89%. Their tool is objective and scalable and their speech biomarkers are available in #multiplelanguages.

The contributions these fantastic women are making to the field are phenomenal. As a community, we are excited to support and cheer these impressive #digitalhealth #startups and their #CEOs! Happy #WomensHistoryMonth!

Shwen Gwee, Laura Gunn, Meredith Cohen, Shrawan Patel, MD, Elizabeth Otter, MPH Marc Monseau, Christopher L. Salzo, Veena Rao, Katherine Vandebelt, Nishta Rao, #pharmstarsalumni #pharma #biopharma #biotech #transformation

Related Questions

What is PharmStars' mission and focus?
How did Naomi Fried start her career in the pharmaceutical industry?
What are some notable projects PharmStars has been involved in?
How has Naomi Fried's leadership style influenced PharmStars?
What are the key achievements of PharmStars under Naomi Fried's leadership?
Naomi Fried
Naomi Fried, photo 1
Naomi Fried, photo 2
Add to my network

Location

Greater Boston